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Appendix	A:	Contraction	Profile	Data		
	
Figure	A1:	Contraction	profile	of	cells	in	the	presence	of	various	hormones	treated	with	0.2	ng/mL	of	IL-
1β.	
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Figure	A2:	Contraction	profile	of	cells	in	the	presence	of	various	hormones	treated	with	0.2	ng/mL	of	
TGF-β.	
	
Figure	A3:	Contraction	profile	of	cells	in	the	presence	of	various	hormones	treated	with	0.2	ng/mL	of	
TNF-α.		
